These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 7679733)

  • 1. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta-opioid-receptor activation by [D-Pen2,D-Pen5]enkephalin and morphine inhibits substance P release from trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    Eur J Pharmacol; 1992 Dec; 229(1):1-7. PubMed ID: 1282103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
    Alcaraz C; Vargas ML; Fuente T; Milanés MV
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of mu and kappa opioid receptor agonists on cAMP level in hippocampus of kainic acid-treated rats.
    Dziedzicka-Wasylewska M; Przewłocki R
    Pol J Pharmacol; 1995; 47(2):121-6. PubMed ID: 8688884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of a mu- and kappa-opioid agonist on isoflurane minimal anesthetic concentration in chickens.
    Concannon KT; Dodam JR; Hellyer PW
    Am J Vet Res; 1995 Jun; 56(6):806-11. PubMed ID: 7653892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
    Millan MJ; Morris BJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
    Tiseo PJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1988 Aug; 246(2):449-53. PubMed ID: 2900324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
    Nakazawa T; Furuya Y; Kaneko T; Yamatsu K; Yoshino H; Tachibana S
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1247-54. PubMed ID: 1969472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
    Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
    Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y; Gafni M; Keren O; Sarne Y
    Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine produces a multiphasic effect on the release of substance P from rat trigeminal nucleus slices by activating different opioid receptor subtypes.
    Suarez-Roca H; Maixner W
    Brain Res; 1992 May; 579(2):195-203. PubMed ID: 1378347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors.
    Utz J; Eckert R; Trautwein W
    J Pharmacol Exp Ther; 1995 Aug; 274(2):627-33. PubMed ID: 7543570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.